A Phase 1 interventional study of SymTrend, Inc. in Vascular Dementia, sponsored by SymTrend Inc.. Status unknown at 1 site in United States. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2018-10-11.
Sponsored by SymTrend Inc. · Phase 1, Interventional, and Prevention
Individuals with uncontrolled vascular disease are at risk for an insidious progression of brain injury starting in early to midlife and ultimately culminating in a vascular dementia, robbing them of activities of daily living independence. Successful containment of this progression requires rigorous vascular risk factor management - the control of blood pressure, blood sugars, weight, and alcohol consumption; the cessation of smoking, and an increase in aerobic activity. SymTrend's mobile and web system for managing vascular risk factors will help improve adherence to health and lifestyle strategies, will stem cognitive decline, and will preserve independence in the community for older adults.
Neurologists from Massachusetts General Hospital will refer 10 adults with vascular mild cognitive impairment for participation in this project. The patients will be given Bluetooth devices appropriate for their condition and will be trained to use SymTrend and Apple Health software. They will use the software and devices for three months; will receive messages throughout from the system and/or a research coordinator about their progress, with encouragement and strategies to fully manage their symptoms; and their neurologist will be in communication with them about the progress charts and will adjust their care on the basis of this real-time data.
2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.
This study's planned enrollment of 10 is below the median of 83 across 1,629 interventional studies indexed under Dementia.
Browse Dementia studies →SymTrend Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Use of SymTrend and Apple Health apps with feedback and strategies provided.
Improved management of blood sugar
Blood sugars are measured regularly and are maintained within bounds prescribed by MD
Time frame: three months
Improved blood pressure management
Blood pressure is measured regularly and is within bounds prescribed by MD
Time frame: three months
Reduced smoking
Number of cigarettes smoked is reduced or eliminated
Time frame: three months
Weight is reduced if necessary
Food intake is reduced and is healthier, and as a consequence weight is reduced
Time frame: three months
Activity level is increased
Step count increases continuously throughout study period
Time frame: three months
Fatigue is reduced if originally is a problem
Hours sleep increases and frequency of sleep interruption reduces
Time frame: three months
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
SymTrend Inc.